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OBJECTIVES: To determine if capillary rarefaction persists when hypertension is treated with angiotensin converting enzyme 
inhibitor, thiazidic diuretic and/or beta-blocker, and to identify which microcirculatory alterations (structural and functional) persist 
after anti-hypertensive treatment. 
METHODS: We evaluated 28 well-controlled essential hypertensive patients and 19 normotensive subjects. Nailfold videocapil-
laroscopy examination of the fourth finger of the left hand was used to determine the functional capillary densities at baseline, 
during post-occlusive hyperemia, and after venous congestion. Capillary loop diameters (afferent, apical and efferent) and red 
blood cell velocity were also quantified. 
RESULTS: Compared with normotensive subjects, hypertensive patients showed lower mean functional capillary density at baseline 
(25.1±1.4 vs. 33.9±1.9 cap/mm², p<0.01), during post-occlusive reactive hyperemia (29.3±1.9 vs. 38.2±2.2 cap/mm², p<0.01) and 
during venous congestion responses (31.4±1.9 vs. 41.1±2.3 cap/mm², p<0.01). Based on the density during venous congestion, the 
estimated structural capillary deficit was 25.1%. Mean capillary diameters were not different at the three local points, but red blood 
cell velocity at baseline was significantly lower in the hypertensive group (0.98±0.05 vs. 1.17±0.04 mm/s, p<0.05). 
CONCLUSIONS: Patients treated for essential hypertension showed microvascular rarefaction, regardless of the type of therapy 
used. In addition, the reduced red blood cell velocity associated with capillary rarefaction might reflect the increased systemic 
vascular resistance, which is a hallmark of hypertension. 
KEYWORDS: Anti-hypertensive drugs; Microcirculation; Microvascular dysfunction; Videocapillaroscopy.
INTRODUCTION
Increased peripheral vascular resistance is related 
to essential hypertension.1 The microcirculation largely 
determines peripheral resistance and consequently 
contributes to arterial hypertension.2-4 In both human 
arterial hypertension and animal models of hypertension, 
the formation and number of microvessels can be reduced 
by factors that are associated with hypertension, including 
genetic and fetal factors, among others. This microvascular 
rarefaction has been shown to contribute to increased 
peripheral resistance and raised blood pressure. Experimental 
studies have demonstrated rarefaction of the arterioles 
and capillaries in the skeletal muscles of spontaneously 
hypertensive rats.5,6 The first study describing microvascular 
rarefaction in hypertensive human subjects was published 
more than seventy years ago.7 Since then, several studies 
have reported decreased numbers of capillaries in patients 
with untreated hypertension.8-10 
Indeed, there is controversy concerning the origin 
and persistence of capillary rarefaction after treatment 
for hypertension. In recent years, studies using intravital 
capillary videomicroscopy presented results that conflicted 
with other studies that demonstrated structural and functional 
capillary rarefaction.11,12 The videomicroscopy studies used 
techniques that recruit capillaries, such as post-occlusive 
reactive hyperemia and venous congestion responses.13 614
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Venous congestion enhances the visibility of skin capillaries 
when using videomicroscopy. More specifically, the increase 
in number of red blood cells within capillaries, which 
is caused by venous congestion, can lead to mechanical 
opening of the capillaries, thus increasing their visibility by 
videomicroscopy.11,12 
Although a wide variety of pharmacological anti-
hypertensive agents can decrease blood pressure, they seem 
to vary in their ability to reverse structural and functional 
changes in microcirculation. For example, results with 
calcium antagonists have been variable and β-adrenoceptor 
blockers appear to have no effect on microcirculation 
changes.14 There are only a few studies that have evaluated 
the impact of hypertension treatment on functional capillary 
density (number of capillaries with moving red blood cells/
mm²) and they have reported conflicting results.2,15 These 
conflicting data indicate that additional trials are needed 
to evaluate the role of anti-hypertensive drug therapy on 
microcirculation in hypertension.
The objectives of our study were to determine whether 
capillary rarefaction persisted in hypertensive patients treated 
with an angiotensin converting enzyme inhibitor (ACE-i), a 
thiazidic diuretic and/or a β-blocker, and to identify which 
microcirculatory alterations (structural or functional) 
persisted after treatment.
SUBJECTS AND METHODS
Subjects
A total of 28 patients with previous diagnoses of essential 
hypertension in the last ten years and 19 normotensive 
controls were enrolled in this study. Hypertensive patients 
were recruited from a pool of patients that received 
outpatient care at the Hypertension Clinic of a University 
General Hospital, and normotensive subjects were invited 
to participate in the research project during their routine 
consultations at the General Clinic in this hospital. Blacks, in 
whom the research technique does not work well; smokers; 
patients with secondary hypertension; patients with a 
connective tissue or cutaneous disease; and patients with 
diabetes mellitus were excluded. The protocol was approved 
by the local Ethics Committee and all subjects gave their 
written informed consent.
Blood Pressure and Blood Analysis
Blood pressure was measured using a mercury column 
sphygmomanometer whose calibration was previously 
tested at the Brazilian Metrology Institute (INMETRO). 
Each patient’s blood pressure was measured with a cuff, 
which was appropriate for their size, after they had been 
in the sitting position for 5 minutes. Three readings were 
obtained at 2-minute intervals; the mean value was recorded. 
Body weight was recorded in the morning after the patient 
had voided, with the patient wearing indoor clothing 
and no shoes. Venous blood was taken on the day of the 
nailfold videocapillaroscopy examination for the following 
biochemical tests: glucose, creatinine, total cholesterol, 
HDL-cholesterol and triglycerides.
Nailfold Videocapillaroscopy
Nailfold videocapillaroscopy examinations were 
performed as previously described.16 Briefly, the subjects 
acclimated in a temperature-controlled laboratory (24 ± 
2°C) for 30 minutes. All individuals were seated comfortably 
in a fixed, high-based chair with the left upper arm raised 
to heart-level. The forearm and hand rested on a pedestal 
and the fourth finger was supported and gently fixed on 
an acrylic base 2 cm above palm-level with a metal device 
that prevented any movement. The skin temperature was 
monitored with a YSI Precision 4000A digital thermometer 
(Dayton, OH, USA). The thermistor probe was fixed 1 cm 
proximal to the nailfold. Capillary microcirculation was 
observed using a three eyepiece Leica DM/LM microscope 
(Wetzlar, Germany) that was equipped with an epi-
illumination system (100W Xenon lamp). A JVC TK- S250 
video camera was coupled to the microscope and connected 
to a Philips VR 999/78 VCR and a Kodo KBM 1700E 
monitor. All images were recorded on a super VHS tape for 
posterior analysis using CapImage software.17
Two magnifications were used to examine the nailfold 
of the fourth finger of the left hand: 250X for anatomical 
visualization and determination of the functional capillary 
density (number of capillaries with flowing red blood cells 
per tissue area) and 680X for measurement of the capillary 
loop (afferent, apical and efferent) diameters (µm) and the 
baseline red blood cell velocity (mm/s).
Functional Capillary Density (FCD)
We used three microscopic fields at the nailfold for 
measurements: the right lateral, the left lateral and the central 
fields. Baseline capillary density was measured along 3 mm 
of the distal row of capillaries. Each field was recorded for 
30 seconds and the videotape recording was further analyzed 
by two investigators in a blinded fashion.
Importantly, the investigators used the same field 
(central) to compare the capillary density at baseline, at 
venous congestion and during reactive hyperemia responses. 
All patients were maintained comfortably at rest during all 615
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procedures; they did not perform any hand movements. 
Venous Congestion Response
We used a miniature blood pressure cuff applied to the 
base of the left fourth finger inflated at 60 mmHg for 3 
minutes. We visualized the capillaries for 30 seconds during 
the occlusion at the central field, which was previously 
analyzed for baseline functional capillary density. Estimated 
structural capillary deficit was calculated as the percentage 
of discrepancy of the functional capillary density between 
the hypertensive and normotensive subjects after the venous 
congestion response (Figure 1).
Reactive Hyperemia Response
The miniature digital cuff was inflated for 3 minutes 
to 40 mmHg above the patient’s systolic pressure in order 
to stop arterial blood flow to the finger. Then, the cuff was 
deflated abruptly and capillaroscopic images were obtained 
continuously for 30 seconds, under 250X magnification, for 
posterior evaluation of functional capillary density.
Red Blood Cell Velocity 
Capillaries that were easily visualized and had 
intermittent blood flow were analyzed. Data on these 
capillaries were acquired from videotape recordings of the 
capillaries under 680X magnification and analyzed using 
CapImage software and the standard frame-to-frame analysis 
technique.16
Statistical Analysis
The data are presented as mean ± SEM, unless otherwise 
noted. Comparisons between groups were made by the 
Student’s t test (not paired). We tested effects of treatment 
types using one-way ANOVA, with Newman-Kells post-
test to compare all pairs. The data were processed using 
Prism for Windows, version 4.02 (GraphPad Software, 
Inc). Differences with p≤0.05 were considered statistically 
significant.
RESULTS
Subjects
Mean age, body mass index (BMI) and the female to 
male ratio were not significantly different between the 
groups (Table 1). All patients in the hypertensive group 
reported a diagnosis of hypertension in the last 3 to 10 years 
and had sustained blood pressure below 140/90 mmHg for 3 
consecutive months, which was considered adequate by the 
investigators. 
Blood Pressure and Blood Analysis
Although the blood pressure of each subject was 
considered to be under control, the systolic, diastolic and 
mean values in hypertensive patients were higher than those 
obtained in patients in the control group (Table 1). Of those 
patients on anti-hypertensive drugs, 11 (39.3%) were on 
monotherapy, 14 (50%) received two drugs and 3 (10.7%) 
received three drugs. The number of drugs on the patient’s 
treatment regimen was based on their need to achieve blood 
pressure levels below 140/90 mmHg. Seventeen patients 
used an angiotensin converting enzyme inhibitor (ACE-I; 
captopril 50–150 mg per day), 22 used thiazidic diuretics 
(hydrochlorothiazide 12.5–25 mg per day) and 6 used a 
Figure 1 - Visualization of functional capillary density before and after 
venous congestion, showing the increase in the number of capillaries. The 
results were obtained for a normotensive subject
Table 1 - Clinical characteristics and biochemical data for 
hypertensive patients and normotensive subjects
Normotensives 
(n=19)
Hypertensives 
(n=28)
p value
Age, years 50.21 + 1.5 52.64 + 1.5 NS
BMI, Kg/m2 27.6 ± 1.1 30.4 ± 1.4 NS
Glucose, mmol/L 5.4 ± 0.3 5.4 ± 0.2 NS
Total cholesterol, 
mmol/L
5.3 ± 0.7 5.4 ± 0.2 NS
HDL Cholesterol, 
mmol/L
1.1 ± 0.1 1.1 ± 0.1 NS
LDL Cholesterol, 
mmol/L
3.2 ± 0.2 3.3 ± 0.2 NS
Triglycerides, mmol/L 1.3 ± 0.1 1.3 ± 0.2 NS
Creatinine, µmol/L 61.68 ± 4.3 52.8 ± 4.4 NS
Systolic BP, mmHg 122 ± 2 132 ± 2 <0.001
Diastolic BP, mmHg 75 ± 2 84 ± 2 <0.001
Mean BP, mmHg 91 ± 2 100 ± 2 <0.001
NS indicates not significant (p>0.05). BP, blood pressure; BMI, body mass 
index. 616
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β-blocker (propranolol 80–160 mg per day). These patients 
did not use any other types of anti-hypertensive drugs. No 
differences in the biochemical test results were detected 
among the patients (Table 1).
Nailfold Videocapillaroscopy
Compared with normotensive subjects, hypertensive 
patients showed significantly lower mean functional capillary 
densities at baseline, during post-reactive hyperemia and 
during venous congestion responses (Table 2). These 
differences were observed even with two recruitment 
maneuvers (Figure 2). Based on the functional capillary 
density during venous congestion for both groups, the 
estimated structural capillary deficit was 25.1%. 
Mean capillary loop diameters were not different 
among the three points (Table 2), but the red blood cell 
velocity measured at baseline was significantly lower in the 
hypertensive group (Figure 3). 
To prevent bias related to the type of anti-hypertensive 
drug used, we performed a sub-analysis in which we 
compared the total hypertensive group with sub-groups 
of patients without ACEi, thiazidic diuretic or β-blocker 
treatment. The results were similar for all groups, indicating 
that none of the drugs by themselves were able to increase 
either the functional capillary density or the red blood cell 
velocity (Table 3).
DISCUSSION
Altered microcirculation is commonly found in patients 
with essential hypertension, although the cause of this change 
has not been completely elucidated. Our study shows that 
Table 2 - Measured microcirculatory parameters by nailfold 
videocapillaroscopy
Normotensives 
(n=19)
Hypertensives 
(n=28)
p value
Capillary density (capillaries/mm2)
- Baseline 33.9 ± 1.9 25.1 ± 1.4 <0.01
- Reactive Hyperemia  38.2 ± 2.2  29.3 ± 1.9  <0.01
- Venous Congestion 41.1 ± 2.3 31.4 ± 1.9 <0.01
Red blood cell velocity 
(mm/s)
1.17 ± 0.04 0.98 ± 0.05 <0.05
Capillary loop diameter (µm)
- Afferent  5.3 ± 0.2 5.2 ± 0.3 NS
- Apical 7.2 ± 0.4 6.1 ± 0.2 NS
- Efferent  6.5 ± 0.4 6.0± 0.4 NS
NS indicates not significant (p > 0.05).
Figure 2 - Functional capillary densities in normotensive (n=19) and hyper-
tensive (n=28) subjects at baseline and during post-occlusive reactive hype-
remia and venous congestion responses. **p<0.01 for treated hypertensive 
subjects compared with normotensive controls
Figure 3 - Mean red blood cell velocity in capillaries at baseline, com-
parison between normotensive controls (n=19) and treated hypertensive 
patients (n=28)
Table 3 - Measurements performed by nailfold videocapillaroscopy on hypertensive patients per group of anti-hypertensive drugs
Without ACEi 
(n=11)
Without Beta-Block-
er (n=22)
Without Thiazidic 
(n=6)
All Hypertensives 
(n=28)
P value
FCD – Baseline (cap/mm2) 23.4±2.1 26.5±2.0 26.5±3.2 25.1±1.4 NS
FCD - Reactive Hyperemia (cap/mm2) 27.8±3.0 30.2±2.2 31.7±4.0 29.3±1.9 NS
FCD - Venous Congestion (cap/mm2) 29.4±2.7 32.1±2.3 32.0±4.2 31.4±1.9 NS
Red blood cell velocity (mm/s) 1.01±0.10 0.93±0.05 1.04±0.06 0.98±0.05 NS
ACEi, angiotensin converting enzyme inhibitor; FCD, functional capillary density; cap, capillaries; NS indicates not significant.617
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the mean functional capillary densities at rest, during post-
occlusive hyperemia and during venous congestion responses 
were all significantly lower in patients treated for essential 
hypertension than in normotensive controls. Structural 
deficits and significant functional changes contributed to the 
observed microvascular rarefaction. We have also shown that 
treated hypertensive patients showed significant reductions 
in red blood cell velocity measured at the resting state. This 
relatively newly observed relationship may result from 
increased arteriolar sensitivity to vasoconstrictive substances, 
reduction of endothelium-dependent dilation and increased 
oxidative stress.18
Venous congestion is generally considered a valid 
mechanism by which to enhance the visualization of all 
existing capillaries.19,20 Through use of this approach, we 
found that structural capillary rarefaction was approximately 
25.1% in our treated hypertensive subjects. Another 
study, which used intravital videomicroscopy, reported 
an approximately 20% reduction in capillary density in 
patients that had never been treated for hypertension.8 A 
comparable structural capillary deficit was observed on 
the forearm skin of hypertensive patients using intravital 
fluorescein angiography.9 The baseline capillary densities 
detected in the present investigation were lower than those 
reported in the above-mentioned studies. The observed 
discrepancies between these studies could be explained by 
differences in the methods and settings chosen to evaluate 
microcirculation.
In the case of hypertension, capillary rarefaction may 
induce a rise in blood pressure, a relative decrease in 
tissue perfusion and an increased risk of cardiovascular 
disease.21,22 It is widely accepted that capillary rarefaction is 
present in patients with untreated essential hypertension11,12 
and possibly in normotensive offspring of hypertensive 
individuals.23 Persistence of this state after treatment is a 
matter of debate. Furthermore, persistence may depend on 
the type of anti-hypertensive drug that was used during the 
course of treatment.14 Our findings confirmed the results 
reported by Antonios and co-workers showing that capillary 
density was significantly lower in treated patients compared 
with patients who were normotensive.24 Recently, Debbadi 
and collaborators reported different results. In their study, 
skin capillary density was higher in the treated hypertensive 
group compared with either the untreated hypertensive 
patients or the normotensive controls.15 Battegay and co-
workers reported that specific anti-hypertensive drugs, 
such as angiotensin-converting enzyme inhibitors and 
angiotensin-1 receptor blockers, can induce angiogenesis and 
reduce or even reverse microvascular rarefaction; however, 
this was not observed in our study.2 
The post-occlusive reactive hyperemic response is aimed 
to simulate, in a controlled setting, an ischemic situation 
similar to what is commonly found in the capillaries and in 
microcirculation in different diseases. Our objective was to 
produce a dilator response mediated by metabolic and/or 
in situ chemical factors secondary to local auto-regulation 
of blood flow after a period of ischemia. The significant 
difference between baseline capillary density in the 
normotensive group and the maximal functional recruitment 
in the hypertensive group during the reactive hyperemia 
response suggested both a decreased functional tissue blood 
flow at rest and impaired functional recruitment among the 
hypertensives. Thus, treated hypertensive subjects presented 
decreased capillary densities, both at rest and during tissue 
ischemia. 
In the present study, we observed reduced red blood 
cell velocity at baseline in hypertensive subjects. This is an 
interesting finding because it emphasizes the importance 
of functional changes on microvascular rarefaction 
associated with essential hypertension. While, in theory, 
a microcirculatory dysfunction should revert following 
treatment, only a few trials have studied the influence of 
anti-hypertensive drugs on red blood cell velocity and these 
studies have reported conflicting results.25,26 Importantly, 
reduced red blood cell velocity may contribute to target 
organ damage in hypertension, but further studies are 
necessary to confirm this hypothesis.
Increased systemic vascular resistance observed in 
essential hypertension has been attributed to alterations in 
the microvasculature.2,14,18,21,27 These alterations have been 
demonstrated in the skin as well as in other tissues, such 
as skeletal muscle.8 It has been suggested that the capillary 
network may contribute to resistance control by regulating 
the narrow diameter of the capillary or by decreasing the 
number of perfused capillaries.11 We did not observe any 
significant reductions in capillary diameters at any of the 
three local points. On the other hand, the change in red 
blood cell velocity may have affected resistance control. If 
this is the case, the significantly lower capillary flow found 
in treated patients could be a consequence of pre-capillary 
vasoconstriction (which is well documented for essential 
hypertension). 
This study has some limitations. Despite anti-
hypertensive treatment, maintenance of sustained blood 
pressure control in the optimal range in hypertensive patients 
may not have been sufficient to decrease microvascular 
rarefaction. Indeed, three months of blood pressure control 
may have been too short of a time period to allow for 
structural changes in the microcirculation. Lastly, the 
sample size in this study was small; our findings should be 
confirmed in studies with larger sample sizes. The number 
of hypertensive patients employed in this study limited 618
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the statistical power such that we may not have observed 
differences between the groups, especially when comparing 
the effects of the various drugs.
In conclusion, our study has shown that patients 
treated for essential hypertension present microvascular 
rarefaction at the resting state. We confirmed that impaired 
structural and functional factors persisted and that they 
were independent of treatment with therapeutic agents. 
Reduced red blood cell velocity was found to be associated 
with capillary rarefaction and this may have contributed 
to the increased systemic vascular resistance, which is 
a hallmark of the disease. This feature is an important 
functional component of microvascular dysfunction; it likely 
contributes to the pathophysiology of essential hypertension. 
These findings emphasize the need for additional studies of 
microcirculation involving hypertensive subjects in order to 
identify functional factors that may be related to target organ 
damage, especially for cerebrovascular, cardiac and renal 
diseases. Consequently, anti-hypertensive drugs should be 
tested and differentiated in terms of their effectiveness to 
prevent or reverse the microcirculatory damage associated 
with hypertension.
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